Archive ready
2025年5月期 第3四半期決算説明資料
https://www.medical-net.com/common/doc/ir/r07/ir_r07_20250418-2.pdfJune 27, 2026 at 09:45 PM JST•The archive page, viewer, and downloads use this saved version.
June 27, 2026 at 09:45 PM JST·www.medical-net.com
The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
Saved PDF
2025年5月期 第3四半期決算説明資料
StartedJune 27, 2026 at 09:45 PM JST
File size4.24 MB
SHA-256683ea00c82faf9d42b36af0420344411072443bf223a9085b50ac2b4ce1bfbde
About this pageAI generated
This document is the financial results presentation for the third quarter of the fiscal year ending May 2025, reporting a revenue increase of 21.0% year-on-year to 4,421 million yen. However, the net loss attributable to parent shareholders was 145 million yen, primarily due to segment losses in the pre-disease and prevention platform business. The outlook anticipates a total revenue of 6,400 million yen for the fiscal year ending May 2025, with continued investments in human resources and new business initiatives. Overall, strengthening existing businesses and focusing on new ventures are emphasized.